COVID-19 and β-thalassemia: in lieu of evidence and vague nexus

HM Al-Kuraishy, MH Mazhar Ashour, HM Saad… - Annals of …, 2024 - Springer
Abstract Coronavirus disease 19 (COVID-19) is an infectious disease caused by severe
acute respiratory coronavirus 2 (SARS-CoV-2) causing acute systemic disorders and multi …

An overview on thalassemia and challenges during COVID-19

AMA Babker - International Journal of Health Sciences, 2022 - neliti.com
The thalassemia is a group of disorders in which the normal ratio of alpha globin to beta
globin production is disrupted due to a disease-causing variant in one or more of the globin …

COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review

L Okar, M Ali, J Parengal, MA Yassin - Clinical Case Reports, 2020 - Wiley Online Library
COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case
progression and literature review - Okar - 2020 - Clinical Case Reports - Wiley Online …

[HTML][HTML] SARS‐CoV‐2 infection in patients with β‐thalassemia: experience from Lebanon

R Bou‐Fakhredin, H Daadaa, S Koussa… - American journal of …, 2021 - ncbi.nlm.nih.gov
3. Vergara-Lluri ME, Piatek CI, Pullarkat V, et al. Autoimmune myelofibrosis: an update on
morphologic features in 29 cases and review of the literature. Hum Pathol. 2014; 45 (11) …

[HTML][HTML] Epidemiological surveillance of SARSCov2 in β-Thalassemia patients in the last two years: reinfection rate, insights and future challenges

L Torti, F Sorrentino, L Maffei… - … of Hematology and …, 2023 - ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19), the highly contagious viral illness caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has had a catastrophic effect on …

[HTML][HTML] COVID-19 in patients with transfusion dependent thalassemia in Indonesia: characteristics of the disease and patients, and comparison between …

TD Atmakusuma - Hematology Reports, 2021 - ncbi.nlm.nih.gov
People living with transfusion dependent thalassemia have a high risk of getting infected by
COVID-19. This can be caused both by internal factors, namely the formation of …

Prevention and treatment of COVID-19 in patients with benign and malignant blood disorders

EA Saade, LS Hojat, P Gundelly, RA Salata - Best Practice & Research …, 2022 - Elsevier
Patients with moderate to severe immunosuppression, a condition that is common in many
hematologic diseases because of the pathology itself or its treatment, are at high risk for …

COVID-19 in patients with transfusion dependent thalassemia (tdt) in indonesia: characteristics of the disease and patients, and comparison between epidemiological …

TD Atmakusuma - Hematology Reports, 2022 - mdpi.com
Background: People living with transfusion dependent thalassemia have a high risk of
becoming infected with COVID-19. This can be caused by both internal factors, namely the …

[HTML][HTML] Integrative management of critical case of Covid 19 with Ayurveda and modern medicine: A case report

A Nakanekar, S Kulkarni, P Khobarkar… - Journal of Ayurveda and …, 2022 - Elsevier
Covid 19 pandemic has placed challenges in front of medical health fraternity in terms of
management, prevention and immunity building. Effectiveness of any medication has not …

First report of COVID‐19 reinfection in a patient with beta thalassemia major

L Okar, R Ahmad, MA Yassin - Clinical Case Reports, 2021 - Wiley Online Library
First report of COVID‐19 reinfection in a patient with beta thalassemia major - Okar - 2021 -
Clinical Case Reports - Wiley Online Library Skip to Article Content Skip to Article Information …